Global Percutaneous Left Atrial Appendage Closure Device Market Growth 2025-2031

March 2025 | 92 pages | ID: G0FB161FE343EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Percutaneous Left Atrial Appendage Closure Device market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for Percutaneous Left Atrial Appendage Closure Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Percutaneous Left Atrial Appendage Closure Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Percutaneous Left Atrial Appendage Closure Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Percutaneous Left Atrial Appendage Closure Device players cover Abbott Laboratories, AtriCure, Boston Scientific Corporation, Johnson and Johnson, Lifetech Scientific Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Percutaneous Left Atrial Appendage Closure Device Industry Forecast” looks at past sales and reviews total world Percutaneous Left Atrial Appendage Closure Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Percutaneous Left Atrial Appendage Closure Device sales for 2025 through 2031. With Percutaneous Left Atrial Appendage Closure Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Percutaneous Left Atrial Appendage Closure Device industry.

This Insight Report provides a comprehensive analysis of the global Percutaneous Left Atrial Appendage Closure Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Percutaneous Left Atrial Appendage Closure Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Percutaneous Left Atrial Appendage Closure Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Percutaneous Left Atrial Appendage Closure Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Percutaneous Left Atrial Appendage Closure Device.

This report presents a comprehensive overview, market shares, and growth opportunities of Percutaneous Left Atrial Appendage Closure Device market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Endocardial LAA Closure Devices
• Epicardial LAA Closure Devices

Segmentation by Application:

• Hospitals
• Ambulatory Surgery Centres
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Abbott Laboratories
• AtriCure
• Boston Scientific Corporation
• Johnson and Johnson
• Lifetech Scientific Corporation
• Occlutech GmbH
• Biosense Webster Inc
• SentreHeart Inc.
• MEDX Xelerator LP
• Cardia Inc

Key Questions Addressed in this Report

What is the 10-year outlook for the global Percutaneous Left Atrial Appendage Closure Device market?

What factors are driving Percutaneous Left Atrial Appendage Closure Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Percutaneous Left Atrial Appendage Closure Device market opportunities vary by end market size?

How does Percutaneous Left Atrial Appendage Closure Device break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Percutaneous Left Atrial Appendage Closure Device Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Percutaneous Left Atrial Appendage Closure Device by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Percutaneous Left Atrial Appendage Closure Device by Country/Region, 2020, 2024 & 2031
2.2 Percutaneous Left Atrial Appendage Closure Device Segment by Type
  2.2.1 Endocardial LAA Closure Devices
  2.2.2 Epicardial LAA Closure Devices
2.3 Percutaneous Left Atrial Appendage Closure Device Sales by Type
  2.3.1 Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Type (2020-2025)
  2.3.2 Global Percutaneous Left Atrial Appendage Closure Device Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Percutaneous Left Atrial Appendage Closure Device Sale Price by Type (2020-2025)
2.4 Percutaneous Left Atrial Appendage Closure Device Segment by Application
  2.4.1 Hospitals
  2.4.2 Ambulatory Surgery Centres
  2.4.3 Others
2.5 Percutaneous Left Atrial Appendage Closure Device Sales by Application
  2.5.1 Global Percutaneous Left Atrial Appendage Closure Device Sale Market Share by Application (2020-2025)
  2.5.2 Global Percutaneous Left Atrial Appendage Closure Device Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Percutaneous Left Atrial Appendage Closure Device Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Percutaneous Left Atrial Appendage Closure Device Breakdown Data by Company
  3.1.1 Global Percutaneous Left Atrial Appendage Closure Device Annual Sales by Company (2020-2025)
  3.1.2 Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Company (2020-2025)
3.2 Global Percutaneous Left Atrial Appendage Closure Device Annual Revenue by Company (2020-2025)
  3.2.1 Global Percutaneous Left Atrial Appendage Closure Device Revenue by Company (2020-2025)
  3.2.2 Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Company (2020-2025)
3.3 Global Percutaneous Left Atrial Appendage Closure Device Sale Price by Company
3.4 Key Manufacturers Percutaneous Left Atrial Appendage Closure Device Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Percutaneous Left Atrial Appendage Closure Device Product Location Distribution
  3.4.2 Players Percutaneous Left Atrial Appendage Closure Device Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR PERCUTANEOUS LEFT ATRIAL APPENDAGE CLOSURE DEVICE BY GEOGRAPHIC REGION

4.1 World Historic Percutaneous Left Atrial Appendage Closure Device Market Size by Geographic Region (2020-2025)
  4.1.1 Global Percutaneous Left Atrial Appendage Closure Device Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Percutaneous Left Atrial Appendage Closure Device Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Percutaneous Left Atrial Appendage Closure Device Market Size by Country/Region (2020-2025)
  4.2.1 Global Percutaneous Left Atrial Appendage Closure Device Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Percutaneous Left Atrial Appendage Closure Device Annual Revenue by Country/Region (2020-2025)
4.3 Americas Percutaneous Left Atrial Appendage Closure Device Sales Growth
4.4 APAC Percutaneous Left Atrial Appendage Closure Device Sales Growth
4.5 Europe Percutaneous Left Atrial Appendage Closure Device Sales Growth
4.6 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales Growth

5 AMERICAS

5.1 Americas Percutaneous Left Atrial Appendage Closure Device Sales by Country
  5.1.1 Americas Percutaneous Left Atrial Appendage Closure Device Sales by Country (2020-2025)
  5.1.2 Americas Percutaneous Left Atrial Appendage Closure Device Revenue by Country (2020-2025)
5.2 Americas Percutaneous Left Atrial Appendage Closure Device Sales by Type (2020-2025)
5.3 Americas Percutaneous Left Atrial Appendage Closure Device Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Percutaneous Left Atrial Appendage Closure Device Sales by Region
  6.1.1 APAC Percutaneous Left Atrial Appendage Closure Device Sales by Region (2020-2025)
  6.1.2 APAC Percutaneous Left Atrial Appendage Closure Device Revenue by Region (2020-2025)
6.2 APAC Percutaneous Left Atrial Appendage Closure Device Sales by Type (2020-2025)
6.3 APAC Percutaneous Left Atrial Appendage Closure Device Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Percutaneous Left Atrial Appendage Closure Device by Country
  7.1.1 Europe Percutaneous Left Atrial Appendage Closure Device Sales by Country (2020-2025)
  7.1.2 Europe Percutaneous Left Atrial Appendage Closure Device Revenue by Country (2020-2025)
7.2 Europe Percutaneous Left Atrial Appendage Closure Device Sales by Type (2020-2025)
7.3 Europe Percutaneous Left Atrial Appendage Closure Device Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device by Country
  8.1.1 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Revenue by Country (2020-2025)
8.2 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales by Type (2020-2025)
8.3 Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Percutaneous Left Atrial Appendage Closure Device
10.3 Manufacturing Process Analysis of Percutaneous Left Atrial Appendage Closure Device
10.4 Industry Chain Structure of Percutaneous Left Atrial Appendage Closure Device

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Percutaneous Left Atrial Appendage Closure Device Distributors
11.3 Percutaneous Left Atrial Appendage Closure Device Customer

12 WORLD FORECAST REVIEW FOR PERCUTANEOUS LEFT ATRIAL APPENDAGE CLOSURE DEVICE BY GEOGRAPHIC REGION

12.1 Global Percutaneous Left Atrial Appendage Closure Device Market Size Forecast by Region
  12.1.1 Global Percutaneous Left Atrial Appendage Closure Device Forecast by Region (2026-2031)
  12.1.2 Global Percutaneous Left Atrial Appendage Closure Device Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Percutaneous Left Atrial Appendage Closure Device Forecast by Type (2026-2031)
12.7 Global Percutaneous Left Atrial Appendage Closure Device Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Abbott Laboratories
  13.1.1 Abbott Laboratories Company Information
  13.1.2 Abbott Laboratories Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
  13.1.3 Abbott Laboratories Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Abbott Laboratories Main Business Overview
  13.1.5 Abbott Laboratories Latest Developments
13.2 AtriCure
  13.2.1 AtriCure Company Information
  13.2.2 AtriCure Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
  13.2.3 AtriCure Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 AtriCure Main Business Overview
  13.2.5 AtriCure Latest Developments
13.3 Boston Scientific Corporation
  13.3.1 Boston Scientific Corporation Company Information
  13.3.2 Boston Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
  13.3.3 Boston Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Boston Scientific Corporation Main Business Overview
  13.3.5 Boston Scientific Corporation Latest Developments
13.4 Johnson and Johnson
  13.4.1 Johnson and Johnson Company Information
  13.4.2 Johnson and Johnson Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
  13.4.3 Johnson and Johnson Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Johnson and Johnson Main Business Overview
  13.4.5 Johnson and Johnson Latest Developments
13.5 Lifetech Scientific Corporation
  13.5.1 Lifetech Scientific Corporation Company Information
  13.5.2 Lifetech Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
  13.5.3 Lifetech Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Lifetech Scientific Corporation Main Business Overview
  13.5.5 Lifetech Scientific Corporation Latest Developments
13.6 Occlutech GmbH
  13.6.1 Occlutech GmbH Company Information
  13.6.2 Occlutech GmbH Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
  13.6.3 Occlutech GmbH Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Occlutech GmbH Main Business Overview
  13.6.5 Occlutech GmbH Latest Developments
13.7 Biosense Webster Inc
  13.7.1 Biosense Webster Inc Company Information
  13.7.2 Biosense Webster Inc Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
  13.7.3 Biosense Webster Inc Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Biosense Webster Inc Main Business Overview
  13.7.5 Biosense Webster Inc Latest Developments
13.8 SentreHeart Inc.
  13.8.1 SentreHeart Inc. Company Information
  13.8.2 SentreHeart Inc. Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
  13.8.3 SentreHeart Inc. Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 SentreHeart Inc. Main Business Overview
  13.8.5 SentreHeart Inc. Latest Developments
13.9 MEDX Xelerator LP
  13.9.1 MEDX Xelerator LP Company Information
  13.9.2 MEDX Xelerator LP Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
  13.9.3 MEDX Xelerator LP Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 MEDX Xelerator LP Main Business Overview
  13.9.5 MEDX Xelerator LP Latest Developments
13.10 Cardia Inc
  13.10.1 Cardia Inc Company Information
  13.10.2 Cardia Inc Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
  13.10.3 Cardia Inc Percutaneous Left Atrial Appendage Closure Device Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Cardia Inc Main Business Overview
  13.10.5 Cardia Inc Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Percutaneous Left Atrial Appendage Closure Device Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Percutaneous Left Atrial Appendage Closure Device Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Endocardial LAA Closure Devices
Table 4. Major Players of Epicardial LAA Closure Devices
Table 5. Global Percutaneous Left Atrial Appendage Closure Device Sales by Type (2020-2025) & (K Units)
Table 6. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Type (2020-2025)
Table 7. Global Percutaneous Left Atrial Appendage Closure Device Revenue by Type (2020-2025) & ($ million)
Table 8. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Type (2020-2025)
Table 9. Global Percutaneous Left Atrial Appendage Closure Device Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global Percutaneous Left Atrial Appendage Closure Device Sale by Application (2020-2025) & (K Units)
Table 11. Global Percutaneous Left Atrial Appendage Closure Device Sale Market Share by Application (2020-2025)
Table 12. Global Percutaneous Left Atrial Appendage Closure Device Revenue by Application (2020-2025) & ($ million)
Table 13. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Application (2020-2025)
Table 14. Global Percutaneous Left Atrial Appendage Closure Device Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Percutaneous Left Atrial Appendage Closure Device Sales by Company (2020-2025) & (K Units)
Table 16. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Company (2020-2025)
Table 17. Global Percutaneous Left Atrial Appendage Closure Device Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Company (2020-2025)
Table 19. Global Percutaneous Left Atrial Appendage Closure Device Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Percutaneous Left Atrial Appendage Closure Device Producing Area Distribution and Sales Area
Table 21. Players Percutaneous Left Atrial Appendage Closure Device Products Offered
Table 22. Percutaneous Left Atrial Appendage Closure Device Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Percutaneous Left Atrial Appendage Closure Device Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share Geographic Region (2020-2025)
Table 27. Global Percutaneous Left Atrial Appendage Closure Device Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Percutaneous Left Atrial Appendage Closure Device Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Country/Region (2020-2025)
Table 31. Global Percutaneous Left Atrial Appendage Closure Device Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Percutaneous Left Atrial Appendage Closure Device Sales by Country (2020-2025) & (K Units)
Table 34. Americas Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Country (2020-2025)
Table 35. Americas Percutaneous Left Atrial Appendage Closure Device Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Percutaneous Left Atrial Appendage Closure Device Sales by Type (2020-2025) & (K Units)
Table 37. Americas Percutaneous Left Atrial Appendage Closure Device Sales by Application (2020-2025) & (K Units)
Table 38. APAC Percutaneous Left Atrial Appendage Closure Device Sales by Region (2020-2025) & (K Units)
Table 39. APAC Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Region (2020-2025)
Table 40. APAC Percutaneous Left Atrial Appendage Closure Device Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Percutaneous Left Atrial Appendage Closure Device Sales by Type (2020-2025) & (K Units)
Table 42. APAC Percutaneous Left Atrial Appendage Closure Device Sales by Application (2020-2025) & (K Units)
Table 43. Europe Percutaneous Left Atrial Appendage Closure Device Sales by Country (2020-2025) & (K Units)
Table 44. Europe Percutaneous Left Atrial Appendage Closure Device Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Percutaneous Left Atrial Appendage Closure Device Sales by Type (2020-2025) & (K Units)
Table 46. Europe Percutaneous Left Atrial Appendage Closure Device Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Percutaneous Left Atrial Appendage Closure Device
Table 52. Key Market Challenges & Risks of Percutaneous Left Atrial Appendage Closure Device
Table 53. Key Industry Trends of Percutaneous Left Atrial Appendage Closure Device
Table 54. Percutaneous Left Atrial Appendage Closure Device Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Percutaneous Left Atrial Appendage Closure Device Distributors List
Table 57. Percutaneous Left Atrial Appendage Closure Device Customer List
Table 58. Global Percutaneous Left Atrial Appendage Closure Device Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Percutaneous Left Atrial Appendage Closure Device Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Percutaneous Left Atrial Appendage Closure Device Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Percutaneous Left Atrial Appendage Closure Device Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Percutaneous Left Atrial Appendage Closure Device Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Percutaneous Left Atrial Appendage Closure Device Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Percutaneous Left Atrial Appendage Closure Device Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Percutaneous Left Atrial Appendage Closure Device Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Percutaneous Left Atrial Appendage Closure Device Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Percutaneous Left Atrial Appendage Closure Device Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Percutaneous Left Atrial Appendage Closure Device Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Percutaneous Left Atrial Appendage Closure Device Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Abbott Laboratories Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 73. Abbott Laboratories Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
Table 74. Abbott Laboratories Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Abbott Laboratories Main Business
Table 76. Abbott Laboratories Latest Developments
Table 77. AtriCure Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 78. AtriCure Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
Table 79. AtriCure Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. AtriCure Main Business
Table 81. AtriCure Latest Developments
Table 82. Boston Scientific Corporation Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 83. Boston Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
Table 84. Boston Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Boston Scientific Corporation Main Business
Table 86. Boston Scientific Corporation Latest Developments
Table 87. Johnson and Johnson Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 88. Johnson and Johnson Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
Table 89. Johnson and Johnson Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Johnson and Johnson Main Business
Table 91. Johnson and Johnson Latest Developments
Table 92. Lifetech Scientific Corporation Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 93. Lifetech Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
Table 94. Lifetech Scientific Corporation Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Lifetech Scientific Corporation Main Business
Table 96. Lifetech Scientific Corporation Latest Developments
Table 97. Occlutech GmbH Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 98. Occlutech GmbH Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
Table 99. Occlutech GmbH Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Occlutech GmbH Main Business
Table 101. Occlutech GmbH Latest Developments
Table 102. Biosense Webster Inc Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 103. Biosense Webster Inc Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
Table 104. Biosense Webster Inc Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Biosense Webster Inc Main Business
Table 106. Biosense Webster Inc Latest Developments
Table 107. SentreHeart Inc. Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 108. SentreHeart Inc. Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
Table 109. SentreHeart Inc. Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. SentreHeart Inc. Main Business
Table 111. SentreHeart Inc. Latest Developments
Table 112. MEDX Xelerator LP Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 113. MEDX Xelerator LP Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
Table 114. MEDX Xelerator LP Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. MEDX Xelerator LP Main Business
Table 116. MEDX Xelerator LP Latest Developments
Table 117. Cardia Inc Basic Information, Percutaneous Left Atrial Appendage Closure Device Manufacturing Base, Sales Area and Its Competitors
Table 118. Cardia Inc Percutaneous Left Atrial Appendage Closure Device Product Portfolios and Specifications
Table 119. Cardia Inc Percutaneous Left Atrial Appendage Closure Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Cardia Inc Main Business
Table 121. Cardia Inc Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Percutaneous Left Atrial Appendage Closure Device
Figure 2. Percutaneous Left Atrial Appendage Closure Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Percutaneous Left Atrial Appendage Closure Device Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Percutaneous Left Atrial Appendage Closure Device Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Percutaneous Left Atrial Appendage Closure Device Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Country/Region (2024)
Figure 10. Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Endocardial LAA Closure Devices
Figure 12. Product Picture of Epicardial LAA Closure Devices
Figure 13. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Type in 2025
Figure 14. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Type (2020-2025)
Figure 15. Percutaneous Left Atrial Appendage Closure Device Consumed in Hospitals
Figure 16. Global Percutaneous Left Atrial Appendage Closure Device Market: Hospitals (2020-2025) & (K Units)
Figure 17. Percutaneous Left Atrial Appendage Closure Device Consumed in Ambulatory Surgery Centres
Figure 18. Global Percutaneous Left Atrial Appendage Closure Device Market: Ambulatory Surgery Centres (2020-2025) & (K Units)
Figure 19. Percutaneous Left Atrial Appendage Closure Device Consumed in Others
Figure 20. Global Percutaneous Left Atrial Appendage Closure Device Market: Others (2020-2025) & (K Units)
Figure 21. Global Percutaneous Left Atrial Appendage Closure Device Sale Market Share by Application (2024)
Figure 22. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Application in 2025
Figure 23. Percutaneous Left Atrial Appendage Closure Device Sales by Company in 2025 (K Units)
Figure 24. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Company in 2025
Figure 25. Percutaneous Left Atrial Appendage Closure Device Revenue by Company in 2025 ($ millions)
Figure 26. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Company in 2025
Figure 27. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Percutaneous Left Atrial Appendage Closure Device Sales 2020-2025 (K Units)
Figure 30. Americas Percutaneous Left Atrial Appendage Closure Device Revenue 2020-2025 ($ millions)
Figure 31. APAC Percutaneous Left Atrial Appendage Closure Device Sales 2020-2025 (K Units)
Figure 32. APAC Percutaneous Left Atrial Appendage Closure Device Revenue 2020-2025 ($ millions)
Figure 33. Europe Percutaneous Left Atrial Appendage Closure Device Sales 2020-2025 (K Units)
Figure 34. Europe Percutaneous Left Atrial Appendage Closure Device Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Revenue 2020-2025 ($ millions)
Figure 37. Americas Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Country in 2025
Figure 38. Americas Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Country (2020-2025)
Figure 39. Americas Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Type (2020-2025)
Figure 40. Americas Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Application (2020-2025)
Figure 41. United States Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Region in 2025
Figure 46. APAC Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Region (2020-2025)
Figure 47. APAC Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Type (2020-2025)
Figure 48. APAC Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Application (2020-2025)
Figure 49. China Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 53. India Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Country in 2025
Figure 57. Europe Percutaneous Left Atrial Appendage Closure Device Revenue Market Share by Country (2020-2025)
Figure 58. Europe Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Type (2020-2025)
Figure 59. Europe Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Application (2020-2025)
Figure 60. Germany Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 61. France Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Percutaneous Left Atrial Appendage Closure Device Sales Market Share by Application (2020-2025)
Figure 68. Egypt Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Percutaneous Left Atrial Appendage Closure Device Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Percutaneous Left Atrial Appendage Closure Device in 2025
Figure 74. Manufacturing Process Analysis of Percutaneous Left Atrial Appendage Closure Device
Figure 75. Industry Chain Structure of Percutaneous Left Atrial Appendage Closure Device
Figure 76. Channels of Distribution
Figure 77. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Forecast by Region (2026-2031)
Figure 78. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Percutaneous Left Atrial Appendage Closure Device Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Percutaneous Left Atrial Appendage Closure Device Revenue Market Share Forecast by Application (2026-2031)